Form 4: Vaxcyte COO Jim Wassil Transfers 74,000 Shares to Charitable Remainder Trust
SEC Form 4 Filing
Vaxcyte's Chief Operating Officer, Jim Wassil, reported a transfer of 74,000 common stock shares to a charitable remainder trust on December 31, 2024.
Summary
- On December 31, 2024, Jim Wassil, the Chief Operating Officer of Vaxcyte, Inc. (PCVX), transferred 74,000 shares of common stock to a charitable remainder trust.
- Following the transaction, Wassil directly owns 131,695 shares of Vaxcyte common stock.
- The transfer was executed at a price of $0 per share, indicating a gift or donation.
- The reporting of this transaction was delayed due to a delay in receiving the transaction information from the Reporting Person's broker.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing. The delayed reporting is a minor negative, but overall, the sentiment is neutral.
Negatives
- The reporting of the transaction was delayed due to a delay in receiving the transaction information from the Reporting Person's broker.
Industry Context
Form 4 filings are standard disclosures required by the SEC for insiders of publicly traded companies, providing transparency into their transactions in the company's stock.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of the transaction: transfer of 74,000 shares to a charitable remainder trust. |
| 03/03/2025 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.